After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines

30 June 2020 - U.K. officials and Vertex Pharmaceuticals have finally put to rest a years-long battle over access to ...

Read more →

Successful Eloctaq bid should widen access to the drug in the UK

29 June 2020 - The NHS and Sobi UK have come to an agreement that will give people living with ...

Read more →

NICE's evaluations of medicines authorized by EMA with conditional marketing authorization or under exceptional circumstances

25 June 2020 - Products which received conditional marketing authorisation or authorisation in exceptional circumstances by European Medicines Agency up to ...

Read more →

‘Open dialogue’ needed with HTAs to improve access

25 June 2020 - Having worked in the NHS as a hospital pharmacist before moving into market access roles in ...

Read more →

NICE draft guidance does not recommend siponimod for treating secondary progressive multiple sclerosis

25 June 2020 - NICE has today issued draft guidance for public consultation which does not recommend siponimod (Mayzent, Novartis) for ...

Read more →

Cancer patients to benefit from new histology independent treatment

25 June 2020 - Entrectinib (Rozlytrek, Roche), a revolutionary treatment for a range of cancers, is the second histology independent drug ...

Read more →

Looking back, UK patients unhappy with adalimumab biosimilar switch

24 June 2020 - The UK results show how challenging switching to a biosimilar can be, according to patient groups. ...

Read more →

NICE publishes final guidance for Sobi's avatrombopag maleate

24 June 2020 - Avatrombopag maleate is used to treat patients with thrombocytopenia. ...

Read more →

NICE begins phased restart of non-COVID-19 guidance

24 June 2020 - NICE has begun a phased restart of publishing non-COVID-19 guidance as the NHS and wider health ...

Read more →

MHRA extends access to Santhera's DMD drug via the EAMS

23 June 2020 - The UK’s Medicines and Healthcare products Regulatory Agency has renewed for a further year the Early ...

Read more →

Harnessing the power of health taxes

18 June 2020 - Health taxes are a cost effective opportunity for progress in public health. ...

Read more →

Government authorises use of dexamethasone for COVID-19

18 June 2020 - The UK has authorised immediate use of dexamethasone on the NHS, widening access to the first ...

Read more →

UK launches world's first ‘subscription-style’ payment model for antibiotics

18 June 2020 - A government scheme to fuel the development of new antibiotics by offering to pay pharmaceutical companies ...

Read more →

Disagreement on cancer drug decisions in Europe

15 June 2020 - Despite the efforts of the European Union to promote voluntary cooperation among Health Technology Assessment agencies, different ...

Read more →

Final NICE green light for Janssen's Stelara in ulcerative colitis

17 June 2020 - NICE has now issued a final green light for NHS use of Janssen's Stelara (ustekinumab) to ...

Read more →